kabutan

Soiken Holdings Inc.(2385) Summary

2385
TSE Growth
Soiken Holdings Inc.
243
JPY
+2
(+0.83%)
Dec 15, 3:30 pm JST
1.56
USD
Dec 15, 1:30 am EST
Result
PTS
outside of trading hours
241.5
Dec 15, 11:37 pm JST
Summary Chart Historical News Financial Result
PER
211.3
PBR
1.06
Yield
4.12%
Margin Trading Ratio
Stock Price
Dec 15, 2025
Opening Dec 15, 9:00 am
240 JPY 1.53 USD
Previous Close Dec 12
241 JPY 1.54 USD
High Dec 15, 10:15 am
249 JPY 1.59 USD
Low Dec 15, 9:06 am
236 JPY 1.51 USD
Volume
141,400
Trading Value
0.03B JPY 0.22M USD
VWAP
242.79 JPY 1.57 USD
Minimum Trading Value
24,300 JPY 156 USD
Market Cap
6.36B JPY 0.04B USD
Number of Trades
308
Liquidity & Number of Trades
As of Dec 15, 2025
Liquidity
Mid
1-Year Average
312
1-Year High Dec 1, 2025
9,730
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 1,007,300
Nov 28, 2025 0 796,500
Nov 21, 2025 0 827,800
Nov 14, 2025 1,700 1,055,200 620.71
Nov 7, 2025 0 928,000
Company Profile
Soiken Holdings Inc. is a venture business originating from Osaka University. The company's main focus is on cosmetics, but it also engages in functional food evaluation testing and anti-fatigue food products.
Sector
Services
Soiken Holdings Inc. was established as a biotech venture from Osaka University and operates in five business areas: bio-evaluation systems, healthcare support, cosmetics, health supplements, and functional ingredient development. In the bio-evaluation systems business, the company conducts evaluation tests using biomarkers and supports clinical research for pharmaceuticals. The healthcare support business offers services such as health checkups, specific health guidance, and diabetes severity prevention programs. The cosmetics business develops and markets its own brand using placenta extract. In the health supplements business, "Imida Peptide" is sold as the main product. The functional ingredient development business focuses on developing and selling functional materials such as lactoferrin.